Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer
Conditions
- Ovarian Clear Cell Adenocarcinoma
- Recurrent Ovarian Carcinoma
Interventions
- OTHER: Laboratory Biomarker Analysis
- DRUG: Sunitinib Malate
Sponsor
National Cancer Institute (NCI)
Collaborators